Yasuyuki Kawamoto

机构：Hokkaido University, Hokkaido University Hospital, Daido University · ORCID：0000-0002-7706-0015

发表论文 228 篇 · 总被引 2051 次 · h-index 18

代表论文

• Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial (2024 · Journal of Clinical Oncology · 被引 63)
• Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer (2023 · British Journal of Cancer · 被引 34)
• The Short- and Long-Term Surgical Results of Consecutive Hepatopancreaticoduodenectomy for Wide-Spread Biliary Malignancy (2023 · Annals of Surgical Oncology · 被引 10)
• Circulating tumor DNA (ctDNA) analyses in patients with HER2-positive biliary tract cancer (BTC) treated with trastuzumab deruxtecan (T-DXd): Exploratory results from the HERB trial. (2023 · Journal of Clinical Oncology · 被引 10)
• Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101) (2023 · Journal of Clinical Medicine · 被引 9)
• Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer (2024 · British Journal of Cancer · 被引 8)